ARDS - Aridis Pharmaceuticals EPS misses by $0.11 August, 12 2019 04:15 PM Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals (NASDAQ:ARDS): Q2 GAAP EPS of -$1.03 misses by $0.11.Total cash and cash equivalents of $8.5MPress ReleaseMore news on: Aridis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,